首页|干预胃的内镜减重现状与发展趋势

干预胃的内镜减重现状与发展趋势

扫码查看
内镜减重作为一种有效的肥胖治疗手段,减重原理类似于减重代谢手术,可分为食物限制型(干预胃)和吸收障碍型(干预肠).目前,部分内镜减重设备已获得美国食品药品监督管理局批准,而我国在内镜减重领域总体落后于西方国家.现就当下开展干预胃的内镜减重的研究情况做一归纳,旨在为我国肥胖的治疗选择和内镜减重的发展提供参考.
Current status and future perspectives of stomach-targeted endoscopic bariatrics
Endoscopic bariatric treatment(EBT)is an effective method for the treatment of obesity.The principle of weight loss is similar to metabolic bariatric surgery.It can be classified as a food restriction(stomach-targeted)and malabsorption(small intestine-targeted).At present,a lot of EBT devices had been cleared by the US Food and Drug Administration to treat obesity,while the EBT in China lagged behind Western countries.Hence,we reviewed the current stomach-targeted EBT,aiming to provide a reference for the supplement of obesity treatment methods and the development of EBT in China.

obesityendoscopic bariatricmetabolic diseasesstomach

卞景愿、朱宝成、严斌、王存川、彭志勇

展开 >

复旦大学附属中山医院青浦分院普通外科(上海 201700)

复旦大学附属中山医院青浦分院内镜中心(上海 201700)

暨南大学附属第一医院减重中心(广州 510630)

肥胖症 内镜减重 代谢性疾病

上海市青浦区卫生健康委基金

QWJ2022-08

2024

中国普外基础与临床杂志
四川大学华西医院

中国普外基础与临床杂志

CSTPCD
影响因子:0.858
ISSN:1007-9424
年,卷(期):2024.31(4)
  • 36